Dabigatran Etexilate Mesylate C35H45N7O8S structure

C35H45N7O8S structure
Molecular Formula C35H45N7O8S
Average mass 723.839 Da
Boiling Point
Flash Point
Molar Refractivity
Surface Tension
Molar Volume
  • Experimental Physico-chemical Properties
  • Miscellaneous
    • Drug Status:

      approved BIONET-Key Organics BS-1008
    • Bio Activity:

      Dabigatran etexilate mesylate (BIBR 1048MS) is the orally active prodrug of dabigatran. MedChem Express http://www.medchemexpress.com/Linagliptin.html, HY-10274A
      Dabigatran etexilate mesylate (BIBR 1048MS) is the orally active prodrug of dabigatran. Dabigatran is a reversible and selective, direct thrombin inhibitor (DTI) with Ki value of 4.5 nM.;IC50 Value: 4.5 nM (Ki); 10 nM(Thrombin-induced platelet aggregation) [1];In vitro: Dabigatran selectively and reversibly inhibited human thrombin(Ki: 4.5 nM) as well as thrombin-induced platelet aggregation (IC(50): 10 nM), while showing no inhibitory effect on other platelet-stimulating agents.Thrombin generation in platelet-poor plasma (PPP), measured as the endogenous thrombin potential (ETP) was inhibited concentration-dependently (IC(50): 0.56 microM). Dabigatran demonstrated concentration-dependent anticoagulant effects in various species in vitro, doubling the activated partial thromboplastin time (aPTT), prothrombin time (PT) and ecarin clotting time (ECT) in human PPP at concentrations of 0.23, 0.83 and 0.18 microM, respectively [1]. ;In vivo: Dabigatran prolonged the aPTT dose-dependentl MedChem Express HY-10274A
      Metabolism/Protease MedChem Express HY-10274A
      Metabolism/Protease; MedChem Express HY-10274A
      Thrombin MedChem Express HY-10274A

Predicted data is generated using the ACD/Labs Percepta Platform – PhysChem Module

No predicted properties have been calculated for this compound.

Click to predict properties on the Chemicalize site


I'm Anna

Would you like to get such a paper? How about receiving a customized one?

Check it out